Handok Inc. (002390) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Handok Inc. (002390:KRX), powered by AI.

Current Price
₩8,050
P/E Ratio
-51.5
Market Cap
110.8B
Sector
Healthcare
What is the Handok Inc. stock price forecast?

Handok Inc. is currently trading at ₩8,050. View real-time AI analysis on Alpha Lenz.

What is Handok Inc. insider trading activity?

View the latest insider trading data for Handok Inc. on Alpha Lenz.

What is Handok Inc.'s P/E ratio?

Handok Inc.'s P/E ratio is -51.5.

Handok Inc.

KRX · 002390
₩8,050-30(-0.37%)Market closedKRX regular session 09:00–15:30 KST
Ask about Handok Inc.'s future dividend policy...
Alpha Chat Insight

Handok Inc. trades at a P/E of -51.5 (undervalued) with modest ROE of -0.8%.

Ask for details

Company Overview

Handok Inc. is a prominent player in the pharmaceutical industry, engaged in the development, production, and distribution of a wide range of pharmaceutical products. With its core operations centered in South Korea, Handok Inc. focuses on delivering innovative healthcare solutions that encompass prescription drugs, over-the-counter medicines, and medical devices. The company's diverse product portfolio spans therapeutic areas such as cardiovascular diseases, diabetes, vaccines, and various chronic conditions. Handok Inc. has established itself as a critical component of the healthcare sector, consistently investing in research and development to introduce advanced pharmaceuticals that cater to evolving patient needs and medical standards. The company partners with global and regional firms, leveraging strategic alliances to enhance its market reach and technological capabilities. As a publicly traded company, Handok Inc. plays an essential role in South Korea's healthcare landscape, contributing significantly to the country's pharmaceutical exports and healthcare innovation. Its commitment to quality and efficacy underscores its reputation as a trusted provider of essential healthcare solutions across domestic and international markets.

CEO김영진, 백진기
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees948

Company Statistics

FY 2025

Profile

₩110,796,440,650Market Cap
₩535,137,855,360Revenue
13.76MShares Out
948Employees

Margins

29.70%Gross
3.55%EBITDA
0.62%Operating
-1.40%Pre-Tax
-0.42%Net

Valuation

-51.46P/E
0.40P/B
0.21EV/Sales
24.55EV/EBITDA
-9.35P/FCF

Growth (CAGR)

-0.53%Rev 3Yr
1.22%Rev 5Yr
-51.30%Op Inc 3Yr
-35.00%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-0.28%ROA
-0.76%ROE
1.52%ROIC

Financial Health

₩25,067,875,510Cash & Cash Equivalents
₩487,360,871,140Net Debt
184.11%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Handok Inc. (ticker: 002390) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 948 employees. Market cap is $110.8B.

The current price is ₩8,050 with a P/E ratio of -51.46x and P/B of 0.4x.

ROE is -0.76% and operating margin is 0.62%. Annual revenue is $535.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Handok Inc. (002390) Stock Forecast 2026 ₩8,050 — Price, Financials & Analyst Targets | Alpha Lenz